homovanillic acid has been researched along with Fatigue Syndrome, Chronic in 3 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with chronic fatigue syndrome showed a significant reduction in basal plasma levels of MHPG and a significant increase in basal plasma levels of 5-HIAA." | 1.28 | Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. ( Dale, JK; Demitrack, MA; Gold, PW; Kling, MA; Krahn, DD; Straus, SE, 1992) |
| "Bupropion responders were more likely to have trough blood levels above 30 ng/ml (chi 2 = 3." | 1.28 | Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. ( Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Thakur, V | 1 |
| Jamwal, S | 1 |
| Kumar, M | 1 |
| Rahi, V | 1 |
| Kumar, P | 1 |
| Demitrack, MA | 1 |
| Gold, PW | 1 |
| Dale, JK | 1 |
| Krahn, DD | 1 |
| Kling, MA | 1 |
| Straus, SE | 1 |
| Goodnick, PJ | 1 |
| Sandoval, R | 1 |
| Brickman, A | 1 |
| Klimas, NG | 1 |
3 other studies available for homovanillic acid and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Protective Effect of Hemin Against Experimental Chronic Fatigue Syndrome in Mice: Possible Role of Neurotransmitters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Behavior, Animal; Brain; Disease Models, Animal; D | 2020 |
Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings.
Topics: Adult; Anxiety Disorders; Blood-Brain Barrier; Cohort Studies; Depressive Disorder; Fatigue Syndrome | 1992 |
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Stud | 1992 |